Patents by Inventor Sandra Sauerland

Sandra Sauerland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210121577
    Abstract: The invention relates to a film coated tablet for the treatment of acute pain containing 400 mg of ibuprofen, 100 mg of caffeine, 50 to 100 mg of one or more disintegrating agents and to a process for the preparation of the film coated tablet according to the invention.
    Type: Application
    Filed: October 6, 2020
    Publication date: April 29, 2021
    Inventors: Sandra SAUERLAND, Thomas FUERST, Alberto HEGEWISCH, Thomas WEISER
  • Patent number: 10959964
    Abstract: The present invention relates to ambroxol hydrochloride for the treatment of acute pharyngitis, wherein ambroxol hydrochloride as a sprayable composition comprising up to 30 mg/ml ambroxol hydrochloride is administered locally in a dose of 1 to 20 mg.
    Type: Grant
    Filed: March 13, 2012
    Date of Patent: March 30, 2021
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Sandra Sauerland, Julia Elisabeth Boni, Bernd Karl Plohmann
  • Patent number: 10098838
    Abstract: The invention relates to water-soluble granules for preparing a drinkable solution, in particular for preventing or treating symptoms associated with mild to moderate chronic venous insufficiency of the lower extremities, containing at least 20 percent by weight of a concentrated extract of red wine leaves, and to a ready-to-use packaging unit comprising one or more portion sachets which contain the granules according to the invention.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: October 16, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Sandra Sauerland, Sonja Heigenhauser, Uwe Scheuring, Oliver Timm
  • Patent number: 10004774
    Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: June 26, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Julia Boni, Bernd Plohmann, Sandra Sauerland
  • Publication number: 20170252452
    Abstract: The invention relates to a film coated tablet for the treatment of acute pain containing 400 mg of ibuprofen, 100 mg of caffeine, 50 to 100 mg of one or more disintegrating agents and to a process for the preparation of the film coated tablet according to the invention.
    Type: Application
    Filed: July 23, 2015
    Publication date: September 7, 2017
    Inventors: Sandra SAUERLAND, Thomas FUERST, Alberto HEGEWISCH, Thomas WEISER
  • Publication number: 20170231907
    Abstract: The invention relates to water-soluble granules for preparing a drinkable solution, in particular for preventing or treating symptoms associated with mild to moderate chronic venous insufficiency of the lower extremities, containing at least 20 per cent by weight of a concentrated extract of red wine leaves, and to a ready-to-use packaging unit comprising one or more portion sachets which contain the granules according to the invention.
    Type: Application
    Filed: July 21, 2015
    Publication date: August 17, 2017
    Applicant: Sandi-Aventis Deutschland GmbH
    Inventors: Sandra Sauerland, Sonja Heigenhauser, Uwe Scheuring, Oliver Timm
  • Publication number: 20160193267
    Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.
    Type: Application
    Filed: March 10, 2016
    Publication date: July 7, 2016
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Julia BONI, Bernd PLOHMANN, Sandra SAUERLAND
  • Publication number: 20140294995
    Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.
    Type: Application
    Filed: April 1, 2014
    Publication date: October 2, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Julia BONI, Bernd PLOHMANN, Sandra SAUERLAND
  • Publication number: 20140066518
    Abstract: The present invention relates to ambroxol hydrochloride for the treatment of acute pharyngitis, wherein ambroxol hydrochloride as a sprayable composition comprising up to 30 mg/ml ambroxol hydrochloride is administered locally in a dose of 1 to 20 mg.
    Type: Application
    Filed: March 13, 2012
    Publication date: March 6, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Sandra Sauerland, Julia Elisabeth Boni, Bernd Karl Plohmann